As of 2025-08-13, the Relative Valuation of Jiangsu Hengrui Medicine Co Ltd (600276.SS) is 25.29 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 60.85 CNY, the upside of Jiangsu Hengrui Medicine Co Ltd based on Relative Valuation is -58.4%.
The range of the Relative Valuation is 21.56 - 32.35 CNY.
| Range | Selected | |
| Trailing P/E multiples | 25.2x - 30.2x | 25.5x |
| Forward P/E multiples | 18.7x - 23.8x | 20.2x |
| Fair Price | 21.56 - 32.35 | 25.29 |
| Upside | -64.6% - -46.8% | -58.4% |
| Date | P/E |
| 2025-08-12 | 56.74 |
| 2025-08-11 | 56.94 |
| 2025-08-08 | 56.87 |
| 2025-08-07 | 56.70 |
| 2025-08-06 | 57.42 |
| 2025-08-05 | 58.09 |
| 2025-08-04 | 57.81 |
| 2025-08-01 | 57.16 |
| 2025-07-31 | 58.65 |
| 2025-07-30 | 59.29 |
| 2025-07-29 | 59.49 |
| 2025-07-28 | 57.84 |
| 2025-07-25 | 52.59 |
| 2025-07-24 | 53.61 |
| 2025-07-23 | 53.27 |
| 2025-07-22 | 53.53 |
| 2025-07-21 | 54.08 |
| 2025-07-18 | 54.79 |
| 2025-07-17 | 53.83 |
| 2025-07-16 | 53.35 |
| 2025-07-15 | 53.35 |
| 2025-07-14 | 53.34 |
| 2025-07-11 | 53.05 |
| 2025-07-10 | 53.70 |
| 2025-07-09 | 53.32 |
| 2025-07-08 | 49.79 |
| 2025-07-07 | 49.09 |
| 2025-07-04 | 49.66 |
| 2025-07-03 | 48.92 |
| 2025-07-02 | 48.72 |
| 2025-07-01 | 48.91 |
| 2025-06-30 | 48.39 |
| 2025-06-27 | 48.44 |
| 2025-06-26 | 48.56 |
| 2025-06-25 | 49.37 |
| 2025-06-24 | 48.62 |
| 2025-06-23 | 48.45 |
| 2025-06-20 | 48.26 |
| 2025-06-19 | 48.09 |
| 2025-06-18 | 48.31 |
| 2025-06-17 | 48.33 |
| 2025-06-16 | 50.12 |
| 2025-06-13 | 50.25 |
| 2025-06-12 | 52.05 |
| 2025-06-11 | 51.01 |
| 2025-06-10 | 51.40 |
| 2025-06-09 | 50.68 |
| 2025-06-06 | 50.16 |
| 2025-06-05 | 50.24 |
| 2025-06-04 | 51.55 |